SCHEMBL30784355

SCHEMBL30784355

COc1ccc2c(=O)[nH]c(N3CCOCC3)nc2c1Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.50
▸ KMT2A Q03164 5/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ TSHR P16473 2/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ TNKS O95271 5/20 0.42
▸ TNKS2 Q9H2K2 5/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ P2RY12 Q9H244 1/20 0.41
▸ PARP14 Q460N5 1/20 0.41
▸ PARP2 Q9UGN5 2/20 0.40
▸ DCTPP1 Q9H773 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ APAF1 O14727 1/20 0.38
▸ CDC25B P30305 1/20 0.38
▸ CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30783824 0.83 TNKS (0.42) PIM1KMT2AMEN1TSHRHSD17B10
SCHEMBL30784253 0.82 HPGD (0.43) PIM1KMT2AMEN1TSHRHSD17B10
SCHEMBL4985818 0.78 SMN1; SMN2 (0.44) PIM1KMT2AMEN1TSHRHSD17B10
SCHEMBL30054892 0.76 SMN1; SMN2 (0.55) KMT2AMEN1TSHRHSD17B10SMN1; SMN2
SCHEMBL27167464 0.76 SMN1; SMN2 (0.55) KMT2AMEN1TSHRHSD17B10SMN1; SMN2
SCHEMBL30784371 0.73 PRKDC (0.38) KMT2AMEN1TSHRHSD17B10TNKS
SCHEMBL30783861 0.72 KMT2A (0.48) PIM1KMT2AMEN1TSHRHSD17B10
SCHEMBL29295193 0.71 NLRP3 (0.44) KMT2AMEN1TSHRHSD17B10TNKS
SCHEMBL30784436 0.70 PIM1 (0.47) PIM1KMT2AMEN1TSHRHSD17B10
SCHEMBL30784070 0.70 HTR3A (0.47) PIM1KMT2AMEN1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback